Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

Details

Language :

English

ISSN :

0732183X

Volume :

26

Issue :

26

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105660037

Full Text :

https://doi.org/10.1200/JCO.2007.14.8924